key: cord-0993390-2i8tx3l2 authors: Kılıc, Osman; Kalcıoglu, Mahmut Tayyar; Cag, Yasemin; Tuysuz, Ozan; Pektas, Emel; Caskurlu, Hulya; Cetın, Ferihan title: Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss date: 2020-06-12 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.06.023 sha: 1b230b886e1b412bb43bd8f98bee99f276b692de doc_id: 993390 cord_uid: 2i8tx3l2 Abstract Objective The aim of this study is to investigate the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in patients presenting with only sudden sensorineural hearing loss (SSNHL) during the pandemic. Methods The study included 5 male patients who presented with the sole complaint of unilateral SSNHL to the otolaryngology outpatient clinic between April 3 and April 12, 2020. The patients were referred to the infectious diseases clinic to be evaluated for SARS-CoV-2 by using real time polymerase chain reaction (RT-PCR) testing. Results RT-PCR testing for SARS-CoV-2 were positive in one of the patient and negative in rest four patients. We also noted positive response to Coronavirus Disease-19 (COVID-19) specific treatment in SARS-CoV-2 positive SSNHL patient. Conclusion It should be kept in mind that non-specific symptoms such as SSNHL could be the only sign to recognize a COVID-19 case. Awareness of such a non-specific presentation of COVID-19 patients is crucial during this pandemic period for the prevention of infectious spread through isolation and early initiation of COVID-19 targeted treatment. Emerged in Wuhan of China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease (COVID -19) has been causing deaths from pneumonia and respiratory J o u r n a l P r e -p r o o f 3 failure, eventually becoming a pandemic. It was identified as a clade of the family of coronaviruses, isolated from human airway epithelial cells (Zhu et al. 2020 ) and reported as transmitted through droplets and direct contact, with an incubation period of 2-7 days extending up to 14 The study protocol was approved by the Clinical Research Ethics Committee of xxx University (April 9, 2020/0188). The subjects were eligible for the study if presented with the sole complaint of unilateral sudden hearing loss to the otolaryngology outpatient clinic between April 3 and April 12, 2020. SSNHL was defined as a hearing loss of more than 30 dB at three consecutive frequencies at least over a period of less than three days (Weiss et al., 2017) . Audiological tests confirmed SSNHL in all the patients. The patients were then referred to the infectious diseases clinic to be assessed for SARS-CoV-2. Taking strict precautions in a safety cabinet with disposable isolation gown, N95 masks, gloves, and shields, pharyngeal secretion samples were collected from the oropharynx and then the nasopharynx through direct contact of the synthetic fiber swabs with plastic shafts. The samples were sent to the laboratory for real-time polymerase chain reaction (RT-PCR) test. We identified five male patients, with a mean age of 40 . 8 years (range: 29-54 years). Three patients (60%) had SSNHL in the left ear, and two (40%) in the right ear. SSNHL was the only symptom present in all the patients. None of the patients had any other symptoms than SSNHL or any risk factors such as metabolic diseases, ototoxic drug usage, history of trauma, history of upper respiratory tract infections, etc. On audiologic examination with a tuning fork at a frequency of 512 Hz, the Weber test showed lateralization to the right in patients with left-sided hearing loss and to the left in those with right-sided hearing loss. Tympanometry results were type A for all patients, indicating normal middle ear condition. RT-PCR testing for SARS-CoV-2 were positive in one of the patients (20.0%) and negative in the remaining four patients. Pure tone audiometry findings at 250-500-1000-2000-4000-8000 Hz and RT-PCR results were presented at Table 1 . Due to suspicion of COVID-19, no specific treatment for SSNHL was initiated until RT-PCR test results were acquired. After getting the results, four patients negative for COVID-19 received oral prednisolone 1 mg/kg/day tapered till 16 mg at every three days and oral vitamin B-folic acid complex and proton pump inhibitor daily. reported complete resolution of hearing complaints on day 11 of the treatment. Patients #1, #4, and #5 with negative results for COVID-19 reported complete recovery of hearing on day 10, day 11, and day 3 of the treatment, respectively. Patient #3 with a negative test result for COVID-19 reported persistence of his hearing problem on day 11 of the treatment. Control audiologic tests were performed at least 1 month after the treatment and the results were given in the Table 1 . CoV-2 RT-PCR results were treated using routine therapy that includes corticosteroids. According to the results at least one month after treatment, the patient who had COVID-19, totally recovered. One of the patients with SARS-CoV-2 negative had a complete recovery, while one had a partial recovery. No significant improvement on hearing was observed in two patients (Table 1) . Amongst these cases, three showed complete recovery. No improvement has been observed in the fourth case to this day. Considering neurological involvement of SARS-CoV-2, there have been several reports addressing many different neurological manifestations, but not SSNHL. Mao et al. (Mao et al., 2020) reported patients who were presented with only nonspecific neurological symptoms such as dizziness, ataxia or stroke without smell or taste disorders, and neuralgia due to peripheral cranial nerve involvement. They emphasized the need for high levels of vigilance and evaluation of neurological manifestations in the context of SARS-CoV-2 for early diagnosis and prevention of the spread of infection through isolation, particularly in super-spreading patients. Our data suggest that the same approach may also apply to those presenting with SSNHL as the sole symptom. J o u r n a l P r e -p r o o f 7 In our study, we observed COVID-19 in 1 of 5 (20%) patients with SSNHL symptoms with no prior risk factors for hearing loss. This result is important in that it shows that infected patients can also present in clinics with symptoms different from the previously identified ones in the literature. During this pandemic that has been claiming hundreds of thousands of lives, it would be important to recognize every possible symptom of the infection to break the chain transmission. Therefore, even if the sample size is low, our results carry importance for the global public health. To our knowledge, there have been no reports of COVID-19 patients diagnosed with isolated SSNHL. Therefore, our study is the first to bring awareness to the practitioners and researchers to look for SARS-CoV-2 positivity in patients with SSNHL. We hope our study will contribute to the field of Epidemiology and the practice of Otorhinolaryngology by allowing the early detection of these patients, their isolation, the prevention of their infectiousness in the early period, and the early and targeted medical treatment. It should be kept in mind that non-specific symptoms such as SSNHL could be the only sign to recognize COVID-19 cases. Awareness of such a non-specific presentation of COVID-19 patients is crucial during this pandemic period for the prevention of infectious spread through isolation and early initiation of COVID-19 targeted treatment and avoiding potentially harmful standard SSNHL treatment that includes prednisolone. We would like to thank Sermet Can, M.D., Ph.D. from Oxford, UK for his valuable feedback and suggestions during the preparation of the manuscript and language editing. This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. • During the COVID-19 pandemic, it would be important to recognize every possible symptom of the infection to break the chain transmission. • COVID-19 patients could present with nonspecific symptoms other than the commonly known. • Sudden sensorineural hearing loss may be one of the symptoms of COVID-19. • Up to now, there have been no reports of COVID-19 patients diagnosed with isolated sudden sensorineural hearing loss. Middle East Respiratory Syndrome Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques Viral causes of hearing loss: a review for hearing health professionals Long term serious olfactory loss in colds and/or flu Human Coronavirus: Respiratory Pathogens Revisited as Infectious Neuroinvasive, Neurotropic, and Neurovirulent Agents The 2019 Novel Coronavirus (2019-nCoV): Novel Virus, Old Challenges Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice Return of the Coronavirus: 2019-nCoV Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss Herpes simplex virus type 1 and Bell's palsy-a current assessment of the controversy Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV National Health Commission of the People′s Republic of China Cochlear changes after herpes simplex virus infection Medical Journals and the 2019-nCoV Outbreak Identification of viruses in patients with postviral olfactory dysfunction Common Findings in COVID-19 Predictors of hearing recovery in patients with severe sudden sensorineural hearing loss The relationship of the herpesvirus family to sudden hearing loss: a prospective clinical study and literature review Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance V 1.2 The SARS-CoV-2 outbreak: What we know Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection A Novel Coronavirus from Patients with Pneumonia in China